MedTrace Logo

Study of Patient Satisfaction With the Cancer Clinical Trial Experience

NCT00768976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-05-23

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.

The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.

Conditions

Sponsors & Collaborators

  • Summa Health System

    lead OTHER

Principal Investigators

  • Joyce Neading, RHIT, CTR · Summa Health System

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-05-31
Completion
2012-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00768976 on ClinicalTrials.gov